Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30, 2025
Awaiting price reaction for this filing.
Dolphin Medical Services reported Q2 FY26 revenue from operations of Rs. 18.34 lakhs, down about 27% from Rs. 25.24 lakhs in Q2 FY25. Half-year revenue fell to Rs. 35.20 lakhs from Rs. 39.29 lakhs. Despite the revenue dip, the company posted a net profit of Rs. 0.60 lakh in Q2 and Rs. 3.73 lakhs for H1 FY26, up roughly 26% from Rs. 2.97 lakhs a year ago, driven mainly by lower other expenses. The balance sheet shows negative reserves of Rs. 502.31 lakhs, though total equity remains positive at Rs. 1,007.69 lakhs. Cash flow from operations turned negative at Rs. -7.29 lakhs for the half year, compared to a positive Rs. 9.59 lakhs in H1 FY25. The auditor's limited review report is clean with no qualifications.
Weak sales momentum and negative operating cash flow are concerns, but the company swung to profitability versus a FY25 loss. Negative reserves and tiny absolute numbers suggest the stock remains a micro-cap with limited liquidity and risk for retail investors.